Corcept Therapeutics | CORT - 资产

股票价格
46.73
每天变化
0.67 1.45%
每月一次
15.47%
每年
-34.83%
Q2 预测
45.07


金融业
股票价格
USD
资产
USD 836.65M
现金及等价物
USD 120.5M
销售成本
USD 2.55M
流动资产
USD 485.46M
流动负债
USD 166.09M
债务
USD 6.36M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD 0.2
股本和储备
USD 647.81M
销售毛利
USD 199.58M
债务利息支出
USD 823.61M
利息收入
USD 5.02M
市值
USD 4.71B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 15.24M
销售收入
USD 202.12M
销售和管理费用
USD 114.75M
股票
USD 12.87M
贸易债权人
USD 40.44M
应收帐款人
USD 59.79M


资产 更改 日
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
Ardelyx USD 501.6M 15.43M 2025-12
Assertio Holdings USD 319.77M 46M 2025-09
Aurora Cannabis CAD 775.29M 18.43M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Canopy Growth CAD 1.11B 36.35M 2025-12
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
J&J USD 200.89B 1.68B 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Lexicon Pharmaceuticals USD 184.99M 20.94M 2025-12
Merck USD 129.55B 12.02B 2025-09
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Novartis USD 110.95B 3.66B 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12